BackAchilles Therapeutics Plc Overview

Achilles Therapeutics Plc Total Assets

Track Achilles Therapeutics Plc's total assets ($120M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$122.68M
↓ 30.03% YoYΔ $-52.66M vs prior year quarter

Peer average

Loading

Achilles Therapeutics Plc Total Assets History

Loading

Achilles Therapeutics Plc vs. peers: Total Assets Comparison

Loading

Achilles Therapeutics Plc Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Achilles Therapeutics Plc (ACHL) FAQ

Achilles Therapeutics Plc (ACHL) currently reports a total assets of $120M as of September 2024. That compares with $180M in the prior-year period — down 30.0% year over year. Use the charts on this page to explore Achilles Therapeutics Plc's total assets history and peer comparisons.

Achilles Therapeutics Plc's total assets decreased from $180M to $120M — a 30.0% year-over-year decrease (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Achilles Therapeutics Plc reported $120M in total assets as of September 2024. That compares with $180M in the prior-year period — down 30.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $120M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Achilles Therapeutics Plc, and consider following ACHL for alerts when major investors trade the stock.

Achilles Therapeutics Plc is classified in the Healthcare sector. On total assets, it currently shows $120M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ACHL with unrelated industries.